Latest Contracts News

Foresta Group Holdings advances its flagship Kawerau renewable energy project with inclusion in New Zealand’s Fast-Track Approvals Act, a key term sheet with Genesis Energy, and $2 million raised via convertible notes.

Bubs Australia has triumphed in a long-standing legal dispute, winning $26.5 million in arbitration awards against Alpha Group subsidiaries Alice Trading and Willis Trading. The company now faces the challenge of recovering the awarded sums.

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Harmoney Corp upgrades its FY25 cash NPAT guidance to $5.5 million, driven by strong loan book growth and improved margins, while announcing a strategic 5% on-market share buy-back.

Way2VAT Ltd reported a robust 54% increase in Q1 FY25 revenue to A$1.05 million, driven by new client onboarding and higher VAT claim volumes, alongside strategic cost reductions and fresh credit facilities.

GreenHy2 Limited reports a strategic push in Europe with new contracts for its advanced supercapacitor and hydrogen storage technologies, alongside a cash position of $814K and four quarters of funding runway.

Peet Limited has upgraded its FY25 net profit forecast, buoyed by a robust project pipeline and solid settlement progress, signaling sustained growth in the property development sector.

Far East Gold Ltd has advanced its exploration efforts in Indonesia with imminent drilling at Idenburg and Trenggalek, backed by a $4.78 million strategic investment from Xingye Gold, increasing their stake to nearly 20%.

AKORA Resources has confirmed a robust Pre-Feasibility Study for its Bekisopa iron ore project in Madagascar, highlighting strong financial metrics and government support that pave the way for a 2Mtpa direct shipping ore operation.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

Central Petroleum has successfully commissioned two new wells at Mereenie, exceeding production expectations and driving a 22% rise in quarterly revenue despite the lapse of a key gas supply agreement.